(PharmaNewsWire.Com, June 07, 2017 ) Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. Publisher's analysts forecast the global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-transplant-diagnostics-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global transplant diagnostics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of molecular and non-molecular assays. We also consider the revenue generated from pre- and post-transplant diagnostic products and accessories.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Transplant Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
